METTL3 also increases the m6A methylation of lymphoid enhancer-binding factor 1 (LEF1) mRNA, which promotes its protein expression and the progression of prostate cancer by activating the Wnt-β-catenin pathway (Ma, Cao & Zhao, 2020). This evidence concerns the gene METTL3 and prostate carcinoma.